Reyes is the Daily Bruin's News editor and an Editorial Board member. Previously, she was the Science &amp; Health editor covering research, the UCLA health system and graduate school news. She also writes Arts &amp; Entertainment stories and photographs for the Bruin.

Alejandra Reyes-Velarde

News

Sports

Arts

Opinion

The Quad

Photo

Video

Illustrations

Cartoons

Graphics

The Stack

PRIME

Enterprise

Interactives

Podcasts

Games

Classifieds

Print issues

Budget Cuts Explained

Campus

Science & Health

db-story-b

Daily Bruin

UCLA to receive $520M for selling rights to cancer drug - Daily Bruin

UCLA to receive $520M for selling rights to cancer drug

max-snippet:-1, max-image-preview:large, max-video-preview:-1

robots

UCLA will receive $520 million for selling the rights to a prostate cancer medication that campus researchers helped create, officials announced Friday. The deal granted the royalty rights for Xtandi, a prostate cancer drug, to Royalty Pharma, a pharmaceutical investment company.

https://dailybruin.com/2016/03/04/ucla-to-receive-520m-for-selling-rights-to-cancer-drug/

Saturday, March 7, 2026

IN THE NEWS:

UCLA to receive $520M for selling rights to cancer drug

By Alejandra Reyes-Velarde

March 4, 2016 2:06 p.m.